Supporting domestic suppliers also means faster shipping, easier returns if needed, and customer service during Canadian business hours
Retatrutide includes GLP-1 activity, but it is not only a GLP-1 drug
doi: 10.1016/j.peptides.2020.170366
Root cause of most GLP-1 problems in India: not the drug alone When you look carefully, most GLP-1 horror stories in India trace back to a few root causes: Wrong choice of patient (very low BMI, eating disorders, high-risk medical history) Buying and using drugs without a proper prescription or follow-up Rapid dose escalation to chase quick weight loss Not adjusting older diabetes medicines like sulfonylureas and insulin No guidance on diet, hydration, and muscle protection Fixing these root issues can sharply reduce GLP-1 side effects and make these medicines a safer, more useful ally in Indias diabetes and obesity epidemic
It helps manage blood sugar levels by stimulating insulin production in response to meals, while also reducing the amount of glucose produced by the liver